GlassScriptPhysician profile
Brad E Kremer
NPI 1396914230
$6,632.74
in general payments reported to CMS, 2019-2025
42 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $786 · 2021: $1,019 · 2022: $1,019 · 2023: $1,075 · 2024: $1,068 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,175.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $767.66 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $762.27 | 2019-2025 | |
| Glaxosmithkline, LLC. | $577.10 | 2019-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Lilly USA, LLC | $537.41 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $487.10 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $439.08 | 2021-2025 | |
| Amgen INC. | $429.85 | 2019-2025 | Repatha, Otezla, Otezla |
| Teva Pharmaceuticals USA, INC. | $367.28 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $324.70 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $286.04 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.40 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $149.36 | 2021-2025 | |
| Exact Sciences Corporation | $146.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $124.75 | 2020-2021 | |
| Sanofi Pasteur INC. | $110.97 | 2019-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Kremer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.